Clinical trials in the elderly - A concept comes of age

New England Journal of Medicine

Volumn 356, Issue 15, 2007, Pages 1575-1576

  Siu, Lillian L ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;

AGING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CHRONOLOGY; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; EDITORIAL; ELDERLY CARE; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; FUNCTIONAL STATUS; GERIATRIC CARE; GLIOBLASTOMA; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; POLYPHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; AGE; AGED; BRAIN TUMOR; MORTALITY; NOTE; PATIENT SELECTION; SOCIAL PSYCHOLOGY;

AGE FACTORS; AGED; BRAIN NEOPLASMS; CLINICAL TRIALS; GLIOBLASTOMA; HUMANS; PATIENT SELECTION; PREJUDICE;

EID: 34247106224     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe078023     Document Type: Editorial

References (13)

1. Keime-Guibert F, Chinot O, Taillandier L, et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med 2007;356:1527-35.
2. Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr, Albain KS. Underrepresentation of patients 65 years of age or older in cancertreatment trials. N Engl J Med 1999;341:2061-7.
3. Yee KWL, Pater JL, Pho L, Zee B, Siu LL. Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier? J Clin Oncol 2003;21:1618-23.
4. Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003;21:1383-9.
5. Kimmick GG, Peterson BL, Kornblith AB, et al. Improving accrual of older patients to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB360001. J Clin Oncol 2005;23:2201-7.
6. Townsley CA, Selby R, Siu LL. Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol 2005;23:3112-24.
7. Food and Drug Administration. November 1989 guideline for the study of drugs likely to be used in the elderly. Fed Regist 1994;59(102):39398-400. (Accessed March 15, 2007, at http://www.fda.gov/cder/guidance/iche7.pdf.)
8. Kornblith AB, Kemeny M, Peterson BL, et al. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer 2002;95:989-96.
9. Townsley CA, Chan KK, Pond GR, Marquez C, Siu LL, Straus SE. Understanding the attitudes of the elderly towards enrolment into cancer clinical trials. BMC Cancer 2006;6:34.
10. Townsley CA, Pond GR, Oza AM, et al. Evaluation of adverse events experienced by older patients participating in studies of molecularly targeted agents alone or in combination. Clin Cancer Res 2006;12:2141-9.
11. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005;353:123-32.
12. Sonneveld P, de Ridder M, van der Lelie H, et al. Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy. J Clin Oncol 1995;13:2530-9.
13. Gridelli C, Perrone F, Gallo C, et al. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst 2003;95:362-72.